User profiles for Joel Francesqui

Joel Francesqui

Hospital de la Santa Creu i Sant Pau
Verified email at santpau.cat
Cited by 84

Personalized medicine in sarcoidosis: Unravelling biomarkers for targeted care

J Francesqui, P Marrades… - Current opinion in …, 2023 - journals.lww.com
These findings have implications for clinical practice and research. The limitations of
established biomarkers underscore the need for improved diagnostic tools in sarcoidosis. The …

Pulmonary rehabilitation in sarcoidosis: A systematic review and meta-analysis

…, E Gimeno-Santos, L Solis-Navarro, J Francesqui… - Respiratory …, 2023 - Elsevier
Background Exercise intolerance, muscle weakness, dyspnoea, and fatigue are frequent
complications in symptomatic sarcoidosis patients. Pulmonary rehabilitation improves exercise …

[HTML][HTML] Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire

…, M Terwiel, M Elfferich, J Francesqui… - … Vasculitis, and Diffuse …, 2020 - ncbi.nlm.nih.gov
Background: It has been suggested that sarcoidosis patients, especially those on
immunosuppressive medications, are at increased risk for COVID-19 infection and more severe …

[HTML][HTML] The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study

…, A Vizel, D Talwar, I Strambu, J Francesqui… - Respiratory …, 2021 - Elsevier
Objective To study how demographic differences impact disease manifestation of sarcoidosis
using the WASOG tool in a large multicentric study. Methods Clinical data regarding 1445 …

Home oxygen monitoring in patients with interstitial lung disease

SC Cardeñosa, M Palomo, J Francesqui… - Annals of the …, 2022 - atsjournals.org
Methods We included patients with different types of ILDs. The exclusion criteria were as
follows: inability to perform a 6MWT, pulmonary hypertension of more than than 50mm Hg …

[HTML][HTML] Probing the fog life cycles in the Namib Desert

…, C Feigenwinter, A Wicki, J Franceschi… - Bulletin of the …, 2019 - journals.ametsoc.org
Probing the Fog Life Cycles in the Namib Desert in: Bulletin of the American Meteorological
Society Volume 100 Issue 12 (2019) Jump to Content Jump to Main Navigation Logo Logo Logo …

Current treatment of sarcoidosis

J Sellarés, J Francesqui, M Llabres… - Current Opinion in …, 2020 - journals.lww.com
Sarcoidosis therapy is constantly evolving, and new drugs have been added to the
recommended treatments. However, extensive clinical trials are still necessary to optimize …

[HTML][HTML] On the performance of microlysimeters to measure non-rainfall water input in a hyper-arid environment with focus on fog contribution

C Feigenwinter, J Franceschi, JA Larsen… - Journal of Arid …, 2020 - Elsevier
The measurement of non-rainfall atmospheric water input (NRWI) in arid environments requires
instruments that are capable to detect even smallest amounts of total daily water input of …

[HTML][HTML] Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study

…, MA Barrenechea, JS Torres, J Francesqui… - ERJ Open …, 2024 - Eur Respiratory Soc
Background Fibrotic hypersensitivity pneumonitis (fHP) is an immune-mediated interstitial
lung disease caused by sensitisation to chronic allergen inhalation. This study aimed to …

[HTML][HTML] Sarcoidosis phenotypes

J Francesqui, F Hernández-González… - Open Respiratory …, 2021 - ncbi.nlm.nih.gov
Sarcoidosis is a systemic granulomatous disease of unknown cause that predominantly affects
young and middle-aged adults. Intrathoracic involvement including lymphatic nodes and …